UnitedHealthcare prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
UnitedHealthcare reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers UnitedHealthcare's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at UnitedHealthcare →
- Aflibercept at UnitedHealthcare →
- Apixaban at UnitedHealthcare →
- Atezolizumab at UnitedHealthcare →
- Atogepant at UnitedHealthcare →
- Benralizumab at UnitedHealthcare →
- Bevacizumab at UnitedHealthcare →
- Bictegravir at UnitedHealthcare →
- Buprenorphine at UnitedHealthcare →
- Dapagliflozin at UnitedHealthcare →
- Dulaglutide at UnitedHealthcare →
- Dupilumab at UnitedHealthcare →
- Eculizumab at UnitedHealthcare →
- Elexacaftor Tezacaftor Ivacaftor at UnitedHealthcare →
- Empagliflozin at UnitedHealthcare →
- Erenumab at UnitedHealthcare →
- Evolocumab at UnitedHealthcare →
- Faricimab at UnitedHealthcare →
- Fingolimod at UnitedHealthcare →
- Fremanezumab at UnitedHealthcare →
- Galcanezumab at UnitedHealthcare →
- Glecaprevir Pibrentasvir at UnitedHealthcare →
- Guselkumab at UnitedHealthcare →
- Ibrutinib at UnitedHealthcare →
- Imatinib at UnitedHealthcare →
- Inclisiran at UnitedHealthcare →
- Infliximab at UnitedHealthcare →
- Ixekizumab at UnitedHealthcare →
- Lenalidomide at UnitedHealthcare →
- Liraglutide at UnitedHealthcare →
- Lisdexamfetamine at UnitedHealthcare →
- Mepolizumab at UnitedHealthcare →
- Methylphenidate at UnitedHealthcare →
- Naltrexone at UnitedHealthcare →
- Natalizumab at UnitedHealthcare →
- Nintedanib at UnitedHealthcare →
- Nivolumab at UnitedHealthcare →
- Nusinersen at UnitedHealthcare →
- Ocrelizumab at UnitedHealthcare →
- Ofatumumab at UnitedHealthcare →
- Omalizumab at UnitedHealthcare →
- Ozanimod at UnitedHealthcare →
- Palbociclib at UnitedHealthcare →
- Pembrolizumab at UnitedHealthcare →
- Pirfenidone at UnitedHealthcare →
- Ribociclib at UnitedHealthcare →
- Rimegepant at UnitedHealthcare →
- Risankizumab at UnitedHealthcare →
- Rituximab at UnitedHealthcare →
- Rivaroxaban at UnitedHealthcare →
- Sacubitril Valsartan at UnitedHealthcare →
- Secukinumab at UnitedHealthcare →
- Semaglutide at UnitedHealthcare →
- Sofosbuvir at UnitedHealthcare →
- Tafamidis at UnitedHealthcare →
- Tenofovir Alafenamide at UnitedHealthcare →
- Tezepelumab at UnitedHealthcare →
- Tirzepatide at UnitedHealthcare →
- Tofacitinib at UnitedHealthcare →
- Trastuzumab at UnitedHealthcare →
- Upadacitinib at UnitedHealthcare →
- Ustekinumab at UnitedHealthcare →
Generate a UnitedHealthcare PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to UnitedHealthcare's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com